Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis
| Autor: | Saad, Everardo D *, Squifflet, Pierre, Burzykowski, Tomasz, Quinaux, Emmanuel, Delaloge, Suzette, Mavroudis, Dimitris, Perez, Edith, Piccart-Gebhart, Martine, Schneider, Bryan P, Slamon, Dennis, Wolmark, Norman, Buyse, Marc |
|---|---|
| Zdroj: | In The Lancet Oncology March 2019 20(3):361-370 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|